M31.7

Clinical Causes: Autoimmune response where the immune system mistakenly attacks small blood vessels Genetic factors that may predispose individuals to autoimmune conditions Environmental triggers such as infections or exposure to certain chemicals Possibly related to other autoimmune diseases or vasculitides

Key Symptoms: General symptoms such as fatigue, fever, and weight loss Respiratory issues including nasal congestion, sinusitis, or cough Skin manifestations like rashes, purpura, or livedo reticularis Kidney problems presenting as blood in urine, proteinuria, or high blood pressure Muscle and joint pain and swelling Neurological signs such as numbness or weakness

Diagnosis Path: Diagnosing microscopic polyangiitis involves a combination of clinical evaluations and laboratory tests. Healthcare providers may perform: - Blood tests to detect signs of inflammation and markers of autoimmunity - Urinalysis to assess kidney involvement - Imaging studies such as chest X-rays or CT scans to identify lung involvement - Biopsy of affected tissues, often skin or kidney, to observe characteristic features of vasculitis Early diagnosis is critical, as MPA can mimic other conditions and requires targeted treatment strategies.

Treatment Protocols: Management of microscopic polyangiitis generally involves medications aimed at suppressing the immune response and reducing inflammation. These may include: - Corticosteroids like prednisone to quickly control inflammation - Immunosuppressive agents such as cyclophosphamide or methotrexate - Plasmapheresis in severe cases to remove harmful antibodies Regular monitoring for potential side effects and organ function is essential during treatment. The goal of therapy is to induce and maintain remission, prevent relapses, and minimize organ damage.